Proteome Sciences plc
PRM.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | £9,003 | £10,141 | £10,506 | £13,372 |
| - Cash | £263 | £1,128 | £1,208 | £2,027 |
| + Debt | £15,393 | £14,522 | £13,621 | £13,475 |
| Enterprise Value | £24,133 | £23,534 | £22,919 | £24,820 |
| Revenue | £1,857 | £2,670 | £2,217 | £1,818 |
| % Growth | -30.4% | 20.4% | 21.9% | – |
| Gross Profit | -£90 | £58 | £612 | -£12,622,910 |
| % Margin | -4.8% | 2.2% | 27.6% | -694,329.5% |
| EBITDA | -£1,208 | -£240 | -£1,276 | -£1,262 |
| % Margin | -65.1% | -9% | -57.6% | -69.4% |
| Net Income | -£2,140 | -£1,193 | -£2,213 | -£1,865 |
| % Margin | -115.2% | -44.7% | -99.8% | -102.6% |
| EPS Diluted | -0.007 | -0.004 | -0.008 | -0.006 |
| % Growth | -80% | 46.7% | -19% | – |
| Operating Cash Flow | -£897 | -£312 | -£514 | -£8,961,000 |
| Capital Expenditures | -£58 | -£215 | -£9 | -£1,718,000 |
| Free Cash Flow | -£955 | -£527 | -£523 | -£10,679,000 |